Guardant Health Files 8-K for Material Agreement

Ticker: GH · Form: 8-K · Filed: 2025-04-09T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Guardant Health just signed a big deal, check the 8-K.

AI Summary

Guardant Health, Inc. entered into a material definitive agreement on April 3, 2025. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The company is a medical laboratory services provider based in Palo Alto, California.

Why It Matters

This 8-K filing signals a significant new agreement or financial commitment for Guardant Health, which could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — Material definitive agreements and new financial obligations can introduce significant risks and opportunities that are not yet fully disclosed.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Guardant Health?

The filing states that Guardant Health, Inc. entered into a material definitive agreement on April 3, 2025, but the specific details of this agreement are not provided in the excerpt.

What type of financial obligation is mentioned in the filing?

The filing mentions the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of a registrant.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on April 3, 2025.

Where is Guardant Health, Inc. headquartered?

Guardant Health, Inc.'s principal executive offices are located at 3100 Hanover Street, Palo Alto, California 94304.

What is Guardant Health's primary business classification?

Guardant Health, Inc. is classified under SERVICES-MEDICAL LABORATORIES [8071].

From the Filing

0001193125-25-076885.txt : 20250409 0001193125-25-076885.hdr.sgml : 20250409 20250409163708 ACCESSION NUMBER: 0001193125-25-076885 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250403 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250409 DATE AS OF CHANGE: 20250409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 25825618 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 8-K 1 d937351d8k.htm 8-K 8-K false 0001576280 0001576280 2025-04-03 2025-04-03     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 3, 2025     GUARDANT HEALTH, INC. (Exact name of registrant as specified in its charter)       Delaware   001-38683   45-4139254 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (IRS Employer Identification No.) 3100 Hanover Street Palo Alto , California 94304 (Address of principal executive offices) (Zip Code) 855 - 698-8887 (Registrant’s telephone number, include area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.00001 par value per share   GH   The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01. Entry into a Material Definitive Agreement. On April 3, 2025, Guardant Health, Inc. (the “Company”) entered into a third amendment to the lease (“Third Amendment”) dated November 1, 2014 between the Company and Metropolitan Life Insurance Company (the “Landlord”), as amended on October 17, 2017 and March 6, 2019 (collectively, the “Lease Agreement”), relating to the Company’s existing multibuilding facility located in Redwood City, California. The Third Amendment extends the term of the Lease Agreement to

View on Read The Filing